ATNM
Actinium Pharmaceuticals Inc
1.20$
+0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | -100.0% | – | – | – | |
| – | -0.5% | +8.5% | -12.5% | +6.9% | +1.0% | +0.5% | -0.5% | +1.0% | -398.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | +583.3% | -135.8% | – | – | |
| – | -30.7% | -18.9% | +34.5% | +10.8% | -51.9% | +67.1% | -36.6% | -12.9% | +15.6% | -14.5% | +28.0% | – | |
| – | -15.5% | +28.4% | +21.3% | -21.3% | -4.7% | +231.8% | -70.6% | -41.5% | +38.0% | -19.6% | +20.9% | – | |
| – | -27.7% | -8.3% | +30.4% | +1.4% | -41.1% | +127.9% | -54.9% | -22.9% | +21.6% | -19.1% | +30.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +128.3% | -68.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.